Cargando…
Stereotactic radiosurgery combined with nivolumab or Ipilimumab for patients with melanoma brain metastases: evaluation of brain control and toxicity
PURPOSE: To investigate the efficacy and safety of concurrent stereotactic radiosurgery (SRS) and ipilimumab or nivolumab in patients with untreated melanoma brain metastases. PATIENTS AND METHODS: Eighty consecutive patients with 326 melanoma brain metastases receiving SRS in combination with ipili...
Autores principales: | Minniti, Giuseppe, Anzellini, Dimitri, Reverberi, Chiara, Cappellini, Gian Carlo Antonini, Marchetti, Luca, Bianciardi, Federico, Bozzao, Alessandro, Osti, Mattia, Gentile, Pier Carlo, Esposito, Vincenzo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6458744/ https://www.ncbi.nlm.nih.gov/pubmed/30975225 http://dx.doi.org/10.1186/s40425-019-0588-y |
Ejemplares similares
-
Leptomeningeal disease and brain control after postoperative stereotactic radiosurgery with or without immunotherapy for resected brain metastases
por: Minniti, Giuseppe, et al.
Publicado: (2021) -
Stereotactic radiosurgery for brain metastases: analysis of outcome and risk of brain radionecrosis
por: Minniti, Giuseppe, et al.
Publicado: (2011) -
Stereotactic Radiosurgery and Ipilimumab Versus Stereotactic Radiosurgery Alone in Melanoma Brain Metastases
por: Nguyen, Steven M, et al.
Publicado: (2017) -
Survival of melanoma patients with brain metastases treated with ipilimumab and stereotactic radiosurgery
por: Tazi, Karim, et al.
Publicado: (2015) -
Fractionated stereotactic radiosurgery for patients with skull base metastases from systemic cancer involving the anterior visual pathway
por: Minniti, Giuseppe, et al.
Publicado: (2014)